We also identified two genes with significantly higher prevalence in the VTT tissues compared with the matched primary tumor tissues, including CELSR2 (30.43 vs. 4.00%, p < 0.05) and TET2 (17.39 vs. 0, p < 0.05, Figure 2C). This evidence concerns the gene TET2 and neoplasm.